Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2799 blog entries.

Maryland

The Prescription Drug Affordability Board’s (PDAB’s) Stakeholder Council will meet virtually on October 26 at 2:00 pm. The agenda and other meeting materials will be available on the Stakeholder Council page of the PDAB’s website prior to the scheduled meeting. Registration is required to attend.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-10-16T12:32:37-04:00October 16, 2026|Maryland|

North Carolina

Reminder of Test and Treat Flu Authority. As pharmacists know, in 2025, the General Assembly authorized pharmacists to implement test and treat programs for influenza. Initially implemented by protocols issued by State Health Director Larry Greenblatt, the Pharmacy and Medical Boards have since adopted these protocols (both a test-and-initiate-treatment protocol and an influenza-prophylaxis protocol) by rule effective August 1, 2026.  

Pharmacists are also reminded of the Board's July 31, 2026, statement concerning pharmacist administration of fall 2026 vaccines.  The statement is available on the Board of Pharmacy's website.   

Also in North Carolina, beginning November 1, controlled substances pharmacy claims billed under Medicaid Direct (Prime Therapeutics), will be denied at the pharmacy point of sale if the prescribing provider has not updated their NCTracks provider enrollment record with an active DEA number. Additional details can be found in this NC Medicaid Bulletin. This policy change follows identification of providers who are prescribing controlled substances but have not indicated this in their NCTracks enrollment record and have not provided their DEA number. Pharmacies may begin seeing increased denials related to this update. Medicaid is continuing outreach to impacted providers to encourage them to update their enrollment records ahead of the November 1 deadline. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-10-16T12:30:45-04:00October 16, 2026|North Carolina|

Oregon

The Prescription Drug Affordability Board (PDAB) posted its agenda and meeting materials for the October 21 meeting. Check the PDAB website for updates prior to the meeting. 

Also in Oregon, the Board of Pharmacy is proposing to adopt the following Oregon Administrative Rules: 

Please review and submit written comment(s) on the proposed rule language including the Fiscal Impact statement and Racial Equity statement. You can find the filing notices and proposed rule text on the Board's website.  

The November 24 Rulemaking Hearing will be held virtually via Teams and begins at 9:30 am.  

If you wish to provide virtual oral testimony in real time during the hearing, please complete and submit the Rulemaking Hearing Testimony Sign-up Form on the Board's website. You may also sign up by submitting your first and last name, email address and which rules/protocols you would like to comment on to pharmacy.rulemaking@bop.oregon.gov no later than 8:30 am on November 24. You will receive a confirmation email and a calendar invitation to join the virtual hearing.  

Written comments must be received by 4:30 pm on November 24. Submit written comments to pharmacy.rulemaking@bop.oregon.gov. 

If you would like to listen to the rulemaking hearing, join the virtual Teams meeting or call: 

(503) 446-4951 Phone Conference ID: 538 650 615 # 

Email all rulemaking inquiries to pharmacy.rulemaking@bop.oregon.gov. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-10-16T12:29:57-04:00October 16, 2026|Oregon|

Pennsylvania

The Board of Pharmacy is scheduled to meet for private executive session at 9:00 am followed by public session at 10:30 am on October 20. The agenda and instructions to join the meeting remotely are on the Board’s website.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-10-16T12:28:49-04:00October 16, 2026|Pennsylvania|

Texas

The Health and Human Services Commission's (HHSC) Vendor Drug Program (VDP) held a Pharmacy Stakeholder meeting and shared the following updates.  

  • Pharmacy Payment Information: VDP emphasized that pharmacies must maintain accurate physical addresses, email addresses, phone numbers and primary contacts in the Texas Medicaid & Healthcare Partnership (TMHP) Provider Enrollment and Management System. Direct deposit changes must be submitted using Form CPA 74-176. Keeping this information current matters because the Comptroller may purge a Texas identification number when no payment or voucher history exists for a full fiscal year.  
  • Continuous Glucose Monitors (CGMs): VDP's planned addition of CGMs to the outpatient drug benefit remains delayed because CMS required pharmacies to enroll as DME suppliers. VDP is seeking removal of the DME requirement and is planning to submit a new state plan amendment (SPA) in November.  
  • Temporary Non-Preferred Drug Rule: VDP implemented the rule required by HB 3286 (2023) that requires new drugs that are available on the formulary but have not yet been reviewed by the Drug Utilization Review (DUR) Board to receive temporary non-preferred status. The related Texas Administrative Code amendment was published in the Texas Register as of October 2 and became effective October 7. Pharmacy organizations should ensure that formulary-management and patient-support teams understand how this temporary status applies while new products await DUR Board review.  
  • Usual and Customary: VDP is developing a Texas Administrative Code amendment to implement House Bill 2402 (2025), a law that excludes fees, charges or rates offered through monthly fee-based membership discount programs from the usual-and-customary fee calculation. VDP stated that the rule must remain limited to the statutory language and cannot extend to third-party discount cards; the exclusion applies only to qualifying membership discount programs.  

Also in Texas, VDP published an update to the VDP Pharmacy Provider Procedure Manual.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-10-16T12:28:09-04:00October 16, 2026|Texas|

Wisconsin

The Wisconsin Immunization Registry (WIR) Unit will host its next WIR User Webinar on October 21 from 11:00 am to 12:00 noon to help users prepare for the new WIR system. Topics will include historical immunizations, updating client records, upcoming system changes and data exchange updates. Register for the WIR User Webinar. 

For more information, contact NACDS’ Jermaine Smith at 703–837–4388.

2026-10-16T12:26:56-04:00October 16, 2026|Wisconsin|
Go to Top